GlassScriptPhysician profile
Fabiola Alouidor
NPI 1427627595
$5,194.50
in general payments reported to CMS, 2019-2025
37 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.58 · 2022: $1,255 · 2023: $1,676 · 2024: $1,025 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,852.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,084.20 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $594.97 | 2021-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $556.10 | 2021-2025 | Ozempic, Rybelsus |
| Amgen INC. | $271.57 | 2022-2025 | Evenity, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.56 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $213.35 | 2021-2025 | Verquvo, Belsomra, Gardasil 9 |
| Exact Sciences Corporation | $211.93 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $201.69 | 2022-2025 | Veozah, Myrbetriq |
| Intuity Medical INC | $183.04 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Lilly USA, LLC | $162.31 | 2022-2025 | Mounjaro, Emgality, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $151.23 | 2024-2025 | |
| Pfizer INC. | $127.56 | 2021-2024 | |
| Glaxosmithkline, LLC. | $124.27 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Daiichi Sankyo INC. | $116.45 | 2021-2023 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $100.73 | 2022-2023 | Rexulti |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $90.36 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Dexcom, INC. | $83.05 | 2022-2024 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $66.49 | 2024-2025 | Voquezna |
| Ardelyx, INC. | $66.08 | 2023-2025 | Ibsrela |
| Kowa Pharmaceuticals America, INC. | $63.86 | 2022-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $62.24 | 2024 | |
| Sumitomo Pharma America, INC. | $51.10 | 2025 | Gemtesa |
| Boston Scientific Corporation | $49.05 | 2022 | |
| Amneal Pharmaceuticals LLC | $44.10 | 2024-2025 | Unithroid |
| Amarin Pharma, INC. | $40.05 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.92 | 2022-2024 | Xifaxan |
| Linus Health, INC. | $26.60 | 2023 | |
| Inspire Medical Systems, INC. | $24.74 | 2024 | Inspire |
| Hologic Sales and Service, LLC | $24.65 | 2023 | Thinprep 2000 Processor |
| Phadia US INC. | $22.07 | 2025 | Immunocap |
| Averitas Pharma INC. | $21.09 | 2023 | Qutenza |
| Shield Therapeutics INC | $20.76 | 2024 | |
| Lundbeck LLC | $20.26 | 2023 | Rexulti |
| Redhill Biopharma INC. | $19.66 | 2022 | |
| Corcept Therapeutics | $18.69 | 2023 | Korlym |
| Alk-Abello, INC | $15.37 | 2024 | Ragwitek, Grastek, Odactra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.35 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabiola Alouidor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.